THURSDAY, Dec. 12, 2024 (HealthDay News) -- Initiation of an automated insulin delivery (AID) system improves glycemic control in children and adolescents with type 1 diabetes (T1D), according to ...

Monthly production output was estimated to have decreased by 0.6% in October 2024; this follows an increase of 0.5% in August 2024 and a decrease of 0.5% in September 2024. Monthly production output ...

comprised of companies committed to reindustrializing America’s manufacturing and production capabilities through advanced AI and technology. The inaugural members include: Anduril Industries ...

In his recent interview, the action superstar revealed that there was a time during the 80s and 90s when big production houses didn't wish to work with him and his father, legendary actor Dharmendra.

After slashing the U.S. prices of several of its insulin products by 75% at the start of 2024, Novo Nordisk is ending the year by announcing similar price reductions for most of its other insulins ...

These RDNA 4 cards, part of the Navi 4X series, are expected to be announced at CES 2025. The RX 8600 should easily outperform the current RTX 4060, potentially giving AMD an advantage in the ...

A federal jury has sided with Insulet, which claimed that the South Korea-based diabetes tech company EOFlow had stolen trade secrets related to its wearable insulin pump, in a case that ...

KUALA LUMPUR, Malaysia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Graphjet Technology (“Graphjet” or “the Company”) (Nasdaq:GTI), a leading developer of patented technologies to produce graphite ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China. The site, located in the Beijing Economic and Technological Development Zone, will be aimed at ...

Insulet sued EOFlow last year. Its lawsuit said EOFlow hired away former Insulet employees to develop its EOPatch, an insulin device similar to Insulet's Omnipod. After failing for six years to ...

Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people in the mainland, nearly 12% of its population, had the illness ...